8-K ·Filed Jun 15, 2026

TFX

TELEFLEX INC
NEUTRAL
Impact 4/10
Horizonweeks Processed3mo ago SEC0001193125-26-271318
8-K material event: Items 1.01
Actionable Insight • Neutral

Monitor upcoming quarterly filings for interest coverage and leverage ratio impacts from the higher coupon and additional buyback debt. Watch for rating agency reactions and completion of strategic divestitures which could alter the credit profile.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
TFX ▲ +3.23% at T+60d
NEUTRAL call ✓ call won +3.23% · α vs SPY +2.23% · entry $127.87 → $132.00
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
-2.28%
call -2.28% · α -1.03%
$124.96
settled 4mo ago
T+5d
-2.82%
call -2.82% · α -0.59%
$124.26
settled 3mo ago
T+20d
+1.79%
call +1.79% · α +1.59%
$130.16
settled 3mo ago
T+60d
+3.23%
call +3.23% · α +2.23%
$132.00
settled 22d ago

Price Chart

Loading chart...

Executive Summary

Teleflex issued $500M of 5.875% senior notes due 2032, using proceeds to redeem its 4.625% senior notes due 2027 and fund $200.3M in share repurchases under a previously announced $1.0B buyback program. The refinancing extends debt maturities but increases the coupon, modestly raising interest expense.

Key Facts

  • Issued $500M aggregate principal of 5.875% senior notes due January 15, 2032
  • Proceeds used to redeem $500M of 4.625% senior notes due 2027 and fund $200.3M in share repurchases
  • Notes are unsecured senior obligations, ranking pari passu with existing senior debt
  • Guaranteed by certain wholly-owned domestic subsidiaries
  • Interest payable semi-annually at 5.875% per annum

Financial Impact

Refinancing increases annual interest expense by ~$6.25M (from 4.625% to 5.875% on $500M) while extending maturity by 5 years; additional $200.3M debt for buybacks increases leverage

interest expensedebt maturity profileleverage

Risk Factors

  • Higher interest expense reduces net income
  • Increased leverage from $200.3M buyback borrowing
  • Execution risk on planned strategic divestitures

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
35% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-271318
Document: d138783d8k.htm0001193125-26-271318
Document: 0001193125-26-271318-index-headers.html0001193125-26-271318
Document: 0001193125-26-271318-index.html0001193125-26-271318
Document: 0001193125-26-271318.txt0001193125-26-271318
9 reports for TFX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for TFX — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
MIXED ★ 6/10
$138.89 $139.96▲ +0.77%▲ +0.17%$124.12 (−10.63%)
Jul 2, 2026
13w ago
Court Ruling
BULLISH ★ 6/10
$133.99 $132.30▼ −1.26%▼ −0.85%$124.12 (−7.37%)
Jun 22, 2026
14w ago
Institutional Cluster
MIXED ★ 4/10
$121.67 $134.61▲ +10.64%▲ +10.78%$124.12 (+2.01%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 4/10
$127.87 $130.16▲ +1.79%▲ +1.59%$124.12 (−2.93%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$132.15 $134.04▲ +1.43%▼ −2.19%$124.12 (−6.08%)
Jun 1, 2026
17w ago
8-K
NEUTRAL ★ 4/10
$127.31 $127.49▲ +0.14%▲ +2.45%$124.12 (−2.51%)
May 27, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$128.90 $127.79▼ −0.86%▲ +1.83%$124.12 (−3.71%)
May 7, 2026
21w ago
8-K
MIXED ★ 6/10
$131.59 $128.56▼ −2.31%▼ −5.44%$124.12 (−5.68%)
Feb 26, 2026
31w ago
8-K
MIXED ★ 7/10
$118.39 $110.38▼ −6.77%▼ −0.36%$124.12 (+4.84%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access